Metolazone
- Product NDC
- 71610-285
- 11-digit product format
- 716100285
- Labeler code
- 71610
- Product ID
- 71610-285_875c85ff-ca13-41b1-bc4e-ca871c3d2cd1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metolazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076732
- Marketing category
- ANDA
- Marketing start
- 2003-12-19
- Substance
- METOLAZONE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide-like Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metolazone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METOLAZONE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | TZ7V40X7VX |
| Rxcui | 197979, 311671 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-285-09 | Metolazone | 9000 in 1 BOTTLE | TABLET | 9000 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-285 | METOLAZONE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Current NDC, Legacy NDC, 1 package rows | 20190604_71f86ee1-9e43-482b-9ad8-ec5d5576f360.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-285-09 | 71610028509 | 9000 TABLET in 1 BOTTLE (71610-285-09) | 9000 tablet | 2019-05-31 | 0000-00-00 | No | No | Current |